DNA rearrangement causes hepatocarcinogenesis in albumin-plasminogen activator transgenic mice.
- 1 December 1992
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 89 (23) , 11523-11527
- https://doi.org/10.1073/pnas.89.23.11523
Abstract
Hepatocyte-directed production of urokinase-type plasminogen activator (uPA) in transgenic mice is hepatotoxic. Infrequently, hepatocytes arise that do not express uPA, due to physical loss of transgene DNA, and these cells clonally repopulate the entire liver within 3 months of birth. Surprisingly, hepatic tumors appear in these mice beginning at 8 months of age despite the fact that uPA is not oncogenic or genotoxic. Analysis of the transgene locus reveals that tumors arise only from a particular subclass of transgene-deficient cells in which the entire transgene array, and possibly a significant amount of flanking DNA, is deleted. Considering that all transgene-deficient regenerative nodules undergo extensive replication but only a subset gives rise to tumors, we propose that loss of genomic DNA, not mitogenesis per se, is a primary carcinogenic determinant in this model of hepatocarcinogenesis.Keywords
This publication has 24 references indexed in Scilit:
- Mitogenesis Is Only One Factor in CarcinogenesisScience, 1991
- Rate-limiting steps: The genetics of pediatric cancersCell, 1991
- Tumor suppressor genesCell, 1991
- Cell Proliferation in CarcinogenesisScience, 1990
- Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activatorCell, 1990
- Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic miceCell, 1989
- Chromosome error propagation and cancerTrends in Genetics, 1989
- Dissecting Multistep Tumorigenesis in Transgenic MiceAnnual Review of Genetics, 1988
- The murine urokinase-type plasminogen activator geneBiochemistry, 1987
- A Transgenic Mouse Model of the Chronic Hepatitis B Surface Antigen Carrier StateScience, 1985